Diabetes
55:865-874,
2006
DOI: 10.2337/diabetes.55.04.06.db05-1178
© 2006 by the American Diabetes Association
5-Aminoimidazole-4-Carboxamide-1-ß-D-Ribofuranoside and Metformin Inhibit Hepatic Glucose Phosphorylation by an AMP-Activated Protein Kinase–Independent Effect on Glucokinase Translocation
Bruno Guigas1,
Luc Bertrand2,
Nellie Taleux1,3,
Marc Foretz4,
Nicolas Wiernsperger5,
Didier Vertommen1,
Fabrizio Andreelli4,
Benoit Viollet4, and
Louis Hue1
1 Hormone and Metabolic Research Unit, School of Medicine, Université catholique de Louvain and Institute of Cellular Pathology, Brussels, Belgium
2 Division of Cardiology, School of Medicine, Université catholique de Louvain, Brussels, Belgium
3 Bioénergétique Fondamentale et Appliquée Institut National de la Santé et de la Recherche Medicalé (INSERM) EMI0221, Université J. Fourier, Grenoble, France
4 Institut Cochin, INSERM U567, Département dEndocrinologie, Métabolisme et Cancer, Université René Descartes Paris 5, Centre national de La Recherche Scientifique, Paris, France
5 Merck-Santé, Lyon, France
Address correspondence and reprint requests to Dr. Bruno Guigas, Hormone and Metabolic Research Unit, Institute of Cellular Pathology, UCL 7529, avenue Hippocrate 75, 1200 Brussels, Belgium. E-mail: bruno.guigas{at}horm.ucl.ac.be
Abbreviations:
ACC, acetyl-CoA carboxylase; AICAR, 5-aminoimidazole-4-carboxamide-1-ß-D-ribofuranoside; AMPK, AMP-activated protein kinase; FBPase-2, fructose-2,6-bisphosphatase; Fru-1-P, fructose 1-phosphate; Fru-6-P, fructose 6-phosphate; Fru-2,6-P2, fructose 2,6-bisphosphate; G6Pase, glucose-6-phosphatase; GKRP, glucokinase regulatory protein; Glc-6-P, glucose 6-phosphate; HBM, hepatocyte basal medium; PFK, 6-phosphofructokinase; PKA, protein kinase A; PKB, protein kinase B
AMP-activated protein kinase (AMPK) controls glucose uptake and glycolysis in muscle. Little is known about its role in liver glucose uptake, which is controlled by glucokinase. We report here that 5-aminoimidazole-4-carboxamide-1-ß-D-ribofuranoside (AICAR), metformin, and oligomycin activated AMPK and inhibited glucose phosphorylation and glycolysis in rat hepatocytes. In vitro experiments demonstrated that this inhibition was not due to direct phosphorylation of glucokinase or its regulatory protein by AMPK. By contrast, AMPK phosphorylated liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase without affecting activity. Inhibitors of the endothelial nitric oxide synthase, stress kinases, and phosphatidylinositol 3-kinase pathways did not counteract the effects of AICAR, metformin, or oligomycin, suggesting that these signaling pathways were not involved. Interestingly, the inhibitory effect on glucose phosphorylation of these well-known AMPK activators persisted in primary cultured hepatocytes from newly engineered mice lacking both liver 1 and 2 AMPK catalytic subunits, demonstrating that this effect was clearly not mediated by AMPK. Finally, AICAR, metformin, and oligomycin were found to inhibit the glucose-induced translocation of glucokinase from the nucleus to the cytosol by a mechanism that could be related to the decrease in intracellular ATP concentrations observed in these conditions.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
O. Goransson, A. McBride, S. A. Hawley, F. A. Ross, N. Shpiro, M. Foretz, B. Viollet, D. G. Hardie, and K. Sakamoto
Mechanism of Action of A-769662, a Valuable Tool for Activation of AMP-activated Protein Kinase
J. Biol. Chem.,
November 9, 2007;
282(45):
32549 - 32560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Tosca, C. Chabrolle, S. Uzbekova, and J. Dupont
Effects of Metformin on Bovine Granulosa Cells Steroidogenesis: Possible Involvement of Adenosine 5' Monophosphate-Activated Protein Kinase (AMPK)
Biol Reprod,
March 1, 2007;
76(3):
368 - 378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Jacobs, S. Lingrell, J. R. B. Dyck, and D. E. Vance
Inhibition of Hepatic Phosphatidylcholine Synthesis by 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside Is Independent of AMP-activated Protein Kinase Activation
J. Biol. Chem.,
February 16, 2007;
282(7):
4516 - 4523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Towler and D. G. Hardie
AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling
Circ. Res.,
February 16, 2007;
100(3):
328 - 341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Rencurel, M. Foretz, M. R. Kaufmann, D. Stroka, R. Looser, I. Leclerc, G. da Silva Xavier, G. A. Rutter, B. Viollet, and U. A. Meyer
Stimulation of AMP-Activated Protein Kinase Is Essential for the Induction of Drug Metabolizing Enzymes by Phenobarbital in Human and Mouse Liver
Mol. Pharmacol.,
December 1, 2006;
70(6):
1925 - 1934.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Meley, C. Bauvy, J. H. P. M. Houben-Weerts, P. F. Dubbelhuis, M. T. J. Helmond, P. Codogno, and A. J. Meijer
AMP-activated Protein Kinase and the Regulation of Autophagic Proteolysis
J. Biol. Chem.,
November 17, 2006;
281(46):
34870 - 34879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-M. Ye, N. Dzamko, A. J. Hoy, M. A. Iglesias, B. Kemp, and E. Kraegen
Rosiglitazone Treatment Enhances Acute AMP-Activated Protein Kinase-Mediated Muscle and Adipose Tissue Glucose Uptake in High-Fat-Fed Rats.
Diabetes,
October 1, 2006;
55(10):
2797 - 2804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Viollet, M. Foretz, B. Guigas, S. Horman, R. Dentin, L. Bertrand, L. Hue, and F. Andreelli
Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders
J. Physiol.,
July 1, 2006;
574(1):
41 - 53.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Diabetes Association.
|
|
| |
|